ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62,430 | -23.7% | 11,455 | -6.1% | 0.00% | – |
Q2 2023 | $81,828 | -23.6% | 12,195 | +0.6% | 0.00% | – |
Q1 2023 | $107,073 | +21.7% | 12,126 | -1.6% | 0.00% | -100.0% |
Q3 2022 | $88,000 | +877.8% | 12,317 | +966.4% | 0.00% | – |
Q2 2022 | $9,000 | -57.1% | 1,155 | -24.4% | 0.00% | – |
Q1 2022 | $21,000 | -4.5% | 1,528 | +98.4% | 0.00% | – |
Q4 2021 | $22,000 | +10.0% | 770 | +30.5% | 0.00% | – |
Q3 2021 | $20,000 | -16.7% | 590 | 0.0% | 0.00% | – |
Q2 2021 | $24,000 | -59.3% | 590 | -59.6% | 0.00% | -100.0% |
Q1 2021 | $59,000 | -15.7% | 1,460 | +22.7% | 0.00% | 0.0% |
Q4 2020 | $70,000 | +18.6% | 1,190 | -0.5% | 0.00% | 0.0% |
Q3 2020 | $59,000 | – | 1,196 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |